Synlogic (SYBX) Revenue & Revenue Breakdown


OverviewOwnershipFinancialsChart

Synlogic Revenue Highlights


Latest Revenue (Y)

$3.37M

Latest Revenue (Q)

$8.00K

Synlogic Revenue by Period


Synlogic Revenue by Year

DateRevenueChange
2023-12-31$3.37M185.68%
2022-12-31$1.18M-32.73%
2021-12-31$1.75M221.83%
2020-12-31$545.00K-75.49%
2019-12-31$2.22M-11.75%
2018-12-31$2.52M3.11%
2017-12-31$2.44M100.00%
2016-12-31-100.00%
2015-12-31-100.00%
2014-12-31-100.00%
2013-12-31-100.00%
2012-12-31--

Synlogic generated $3.37M in revenue during NA 2023, up 185.68% compared to the previous quarter, and up 133.77% compared to the same period a year ago.

Synlogic Revenue by Quarter

DateRevenueChange
2024-03-31$8.00K-99.71%
2023-12-31$2.77M604.58%
2023-09-30$393.00K1022.86%
2023-06-30$35.00K-79.89%
2023-03-31$174.00K64.15%
2022-12-31$106.00K-84.37%
2022-09-30$678.00K346.05%
2022-06-30$152.00K-37.70%
2022-03-31$244.00K-58.78%
2021-12-31$592.00K-35.37%
2021-09-30$916.00K272.36%
2021-06-30$246.00K100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30--100.00%
2020-06-30$445.00K345.00%
2020-03-31$100.00K-91.87%
2019-12-31$1.23M303.28%
2019-09-30$305.00K-12.86%
2019-06-30$350.00K3.55%
2019-03-31$338.00K204.50%
2018-12-31$111.00K-93.84%
2018-09-30$1.80M609.06%
2018-06-30$254.00K-28.25%
2018-03-31$354.00K218.92%
2017-12-31$111.00K-
2017-09-30$111.00K-94.74%
2017-06-30$2.11M1801.80%
2017-03-31$111.00K-
2016-12-31$111.00K100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30--

Synlogic generated $8.00K in revenue during Q1 2024, up -99.71% compared to the previous quarter, and up 7.55% compared to the same period a year ago.

Synlogic Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
ACIUAC Immune SA$14.80M-
STOKStoke Therapeutics$8.78M$4.22M
FRTXFresh Tracks Therapeutics$8.01M-
KRONKronos Bio$6.29M$2.69M
GBIOGeneration Bio$5.90M$4.06M
SYBXSynlogic$3.37M$8.00K
SABSSAB Biotherapeutics$2.24M$263.14K
VCNXVaccinex$570.00K$232.00K
CCCCC4 Therapeutics--
ANTXAN2 Therapeutics--
TARAProtara Therapeutics--
GRTXGalera Therapeutics--
ERASErasca--
PCSAProcessa Pharmaceuticals--
PASGPassage Bio--
MNPRMonopar Therapeutics--
THRDThird Harmonic Bio--
GLUEMonte Rosa Therapeutics-$4.70M
FDMT4D Molecular Therapeutics--
EWTXEdgewise Therapeutics--
SRZNSurrozen--
EFTReFFECTOR Therapeutics--

SYBX Revenue FAQ


Synlogic's yearly revenue for 2023 was $3.37M, representing an increase of 185.68% compared to 2022. The company's yearly revenue for 2022 was $1.18M, representing a decrease of -32.73% compared to 2021. SYBX's yearly revenue for 2021 was $1.75M, representing an increase of 221.83% compared to 2020.

Synlogic's quarterly revenue for Q1 2024 was $8K, a -99.71% decrease from the previous quarter (Q4 2023), and a -95.40% decrease year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $2.77M, a 604.58% increase from the previous quarter (Q3 2023), and a 2512.26% increase year-over-year (Q4 2022). SYBX's quarterly revenue for Q3 2023 was $393K, a 1022.86% increase from the previous quarter (Q2 2023), and a -42.04% decrease year-over-year (Q3 2022).

Synlogic's revenue growth rate for the last 3 years (2021-2023) was 92.19%, and for the last 5 years (2019-2023) was 51.57%.